About
Technology
Issues
FAQ
Links
Official Page
BRCA1 genetic variant to predict survival in metastatic colorectal cancer (mCRC) patients (pts) treated with FOLFIRI/bevacizumab (bev): Results from phase III TRIBE and FIRE-3 trials.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.